Book Summary:
The goal of this Video Leadership Seminar™ is to provide you with critical information on biotechnology company valuations and exit strategies. The DVD features 60 minutes of live video with James Sherblom sharing his best practices on biotechnology venture capital, negotiation strategies and structuring deals. Upon completion of the video, you will have a solid grasp of the most important points to understand in negotiating valuations and exit strategies. Topics covered in the video include: 1) venture capital investment strategies in biotechnology companies;
2) what VCs look for in determining valuations;
3) valuation calculations and multiples;
4) biggest external factors in establishing a valuation;
5) how different venture capital firms differ in their valuation strategy;
6) valuation negotiation strategies and areas for negotiation;
7) biggest mistakes management teams make when negotiating valuations;
8) how VCs value a start up company, profitable company, 10 year old company and other scenarios;
9) various exit strategies for biotechnology companies;
10) IPO strategies;
11) M&A strategies;
12) timing for exit strategies;
13) exit strategy negotiations;
14) raising current and future rounds of capital;
15) top 5 things for a management team to increase valuation. |